Empagliflozin and Cardiac Remodelling in People Without Diabetes

Clinical trial NCT04461041 · COMPLETED

Trial details

NCT number: NCT04461041
Sponsor: Unity Health Toronto
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Cardiovascular Diseases Left Ventricular Hypertrophy

Start date: 2021-04-01
Primary completion: 2022-07-31
Enrollment: 169

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.